SEC Form 4 · accession 0001209191-17-040138
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William F Doyle
Director
Period of report
Jun 14, 2017
Accepted (ET)
Jun 15, 2017 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 14, 2017 | M | 6,498 | $3.59 | A | 91,197 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantsF1 | $3.59 | Jun 14, 2017 | M | 6,498 | D | — | Jul 31, 2017 | Ordinary Shares | 6,498 | 0 | D |
Explanation of responses
- F1Exercisable at any time through July 31, 2017